Functional Annotation Report: sad-I (PP_2488, UniProt Q88K05)

NAD⁺-dependent succinic semialdehyde dehydrogenase of Pseudomonas putida KT2440

0. Identity verification (mandatory)

Verification result: CONFIRMED. The gene symbol (sad-I), organism (P. putida KT2440), EC number (1.2.1.24), and ALDH-family/GabD1-like domains all match the provided target identity and are internally consistent across UniProt, KEGG and GenBank. There is no gene-symbol ambiguity: "sad" denotes succinic aldehyde dehydrogenase, and KT2440 explicitly carries two sad genes (sad-I/PP_2488 and sad-II/PP_3151) plus two gabD genes, all consistent with the SSADH function. This report describes PP_2488.

Evidence caveat. No study has, to my knowledge, purified or genetically dissected PP_2488 specifically. The functional assignment below rests on: (i) authoritative database annotation; (ii) direct biochemistry of the P. putida NAD-preferring SSADH enzyme class; (iii) crystallography + mutagenesis of the close ortholog Sad/YneI; and (iv) my own sequence/structure bioinformatic analysis. Confidence is high for the reaction, cofactor and localization; moderate for the precise dominant physiological pathway (see §5).

1. Summary (answer to the research question)

sad-I encodes a soluble, cytoplasmic, NAD⁺-preferring succinic semialdehyde dehydrogenase (SSADH; EC 1.2.1.24) of the aldehyde-dehydrogenase superfamily. Its primary reaction is the essentially irreversible, NAD⁺-dependent oxidation of the reactive aldehyde succinic semialdehyde (SSA) → succinate, feeding carbon into the TCA cycle. It is the terminal enzyme of the GABA "shunt" (the pathway 4‑aminobutyrate → SSA → succinate) and, more generally, oxidizes SSA produced by several converging catabolic routes (GABA, polyamine/putrescine, and aromatic 4‑hydroxyphenylacetate catabolism), also serving a housekeeping aldehyde-detoxification role. It is one of four SSADH paralogs in KT2440 and belongs to the NAD⁺-specific sad/yneI clade, distinct from the NADP⁺-specific gabD clade that sits in the dedicated GABA-nitrogen operon.

2. Primary function: reaction catalyzed

Reaction: succinate semialdehyde + NAD⁺ + H₂O → succinate + NADH + H⁺ (EC 1.2.1.24; UniProt/KEGG annotation; KEGG Orthology K00135).

SSADHs are ubiquitous enzymes that "catalyze the oxidation of succinic semialdehyde (SSA) to succinic acid in the presence of NAD(P)⁺" (Jang et al., Biochem. Biophys. Res. Commun. 2015; PMID 25888791). Because the aldehyde is oxidized to a carboxylate with concomitant hydride transfer to NAD⁺, the reaction is thermodynamically favorable and physiologically unidirectional (biosynthetic/degradative "clean-up" direction).

Catalytic mechanism (inferred from the fold and conserved residues). The ALDH mechanism proceeds via a catalytic cysteine nucleophile that attacks the aldehyde carbonyl to form a thiohemiacetal, hydride transfer to NAD⁺, and hydrolysis of the resulting thioester, with a conserved glutamate acting as general base. My alignment of sad-I to the crystallographically characterized ortholog Sad/YneI (see §4) locates all of these elements:

• Catalytic nucleophile Cys265 (in the "G‑Q‑V‑C‑I‑S‑S" motif), equivalent to the catalytic Cys268 of Salmonella/E. coli YneI whose side chain sits next to the NAD⁺ nicotinamide ring (Zheng et al., FEBS J. 2013; PMID 23229889).
• Catalytic general base Glu362 (≡ YneI Glu365).
• Substrate-orienting Trp133 (≡ YneI Trp136).
• ALDH cofactor/substrate-binding motifs EPWNFP (131), TGSEGAG (208) and ELGGAD (231).

3. Substrate specificity and cofactor preference

Cofactor: NAD⁺-preferring. The gene is annotated NAD⁺-dependent (EC 1.2.1.24). This is supported by two independent lines of evidence:
- Biochemistry of the enzyme class in P. putida. Sànchez et al. (Biochem. J. / Int. J. Biochem. 1988; PMID 3355840) separated two SSADHs from P. putida. The smaller dimeric enzyme (≈100 kDa; 53 kDa subunit) "acts preferentially with NAD but reduces NADP at 9% of the rate observed for NAD," i.e., a strongly NAD-preferring SSADH — the biochemical counterpart of the sad class to which PP_2488 belongs. (The larger ≈200 kDa enzyme was NADP-dependent and putrescine-induced — the gabD counterpart.)
- Conserved cofactor determinant. The residue shown by mutagenesis to confer NAD⁺ preference in YneI (Lys160) is conserved in sad-I as Lys157 (PMID 23229889; my alignment).

Substrate: succinic semialdehyde, with promiscuity toward related semialdehydes. The physiological substrate is SSA (a 4-carbon ω-aldehyde-carboxylate). NAD-specific SSADHs of this class are, however, catalytically promiscuous:
- Classic work on the E. coli NAD- vs NADP-specific SSADHs found that "the NADP-specific enzyme catalyzes only the oxidation of succinate-semialdehyde… whereas the NAD-specific form is active also towards n-butyraldehyde" (Cozzani et al. 1980; PMID 7004491) — i.e., the NAD-type enzyme (sad-I's class) has broader aldehyde tolerance.
- In engineered E. coli, the native Sad had to be deleted because it oxidizes malate semialdehyde, a non-native C4 semialdehyde, diverting flux from 2,4-dihydroxybutyrate production (Nguyen et al. 2025; PMID 40421117).
- SSADH promiscuity has been repeatedly recruited during adaptive laboratory evolution to repair distinct metabolic deficiencies (He et al., 2024; PMID 39406738).

This promiscuity underlies a general detoxification function: SSADHs "play an important role in… the detoxification of accumulated SSA" (PMID 25888791).

4. Structural and evolutionary evidence

• Fold/oligomer. sad-I is a two-domain (Rossmann-like NAD-binding + catalytic) ALDH-superfamily protein (Gene3D 3.40.605.10 / 3.40.309.10; SSF53720). ALDH-family SSADHs function as homodimers/homotetramers; the P. putida NAD-preferring SSADH was characterized as a ≈100 kDa dimer of 53 kDa subunits (PMID 3355840).
• Orthology. By global alignment, sad-I is most similar to E. coli Sad/YneI (P76149, the NAD⁺-specific SSADH; 41.9–42.4 % identity) and less similar to E. coli GabD (P25526, NADP⁺-specific; 37.5 %). E. coli Sad is explicitly "the succinate-semialdehyde dehydrogenase, Sad (also known as YneI)" (Rodionova et al. 2022; PMID 35508583).
• Paralog family in KT2440. Four SSADHs (all KO K00135): NAD-type sad-I/PP_2488 and sad-II/PP_3151 (43.6 % mutual identity) form one clade; NADP-type gabD-I/PP_0213 and gabD-II/PP_4422 (53.4 % mutual identity) form the other. gabD-I sits immediately downstream of gabT/PP_0214 (4-aminobutyrate aminotransferase), i.e., in the canonical GABA-degradation operon; sad-I does not — it lies in a cluster of other aldehyde/xenobiotic-processing enzymes (adjacent aldehyde dehydrogenase PP_2487; OYE-family N-ethylmaleimide reductase PP_2486; xenobiotic reductases).
• Active-site conservation (my alignment to Sad/YneI): catalytic Cys265 (≡Cys268), general base Glu362 (≡Glu365), substrate Trp133 (≡Trp136), NAD⁺-preference Lys157 (≡Lys160). All four are conserved (one YneI residue, Asp426, aligns to Arg423 near an indel — the only divergence).

5. Biological process / pathway context

The unifying theme is that succinic semialdehyde is a metabolic hub aldehyde produced by several catabolic routes, and sad-I oxidizes it to succinate for entry into the TCA cycle:

1. GABA shunt (4-aminobutyrate degradation). GABA is transaminated (GABA aminotransferase) to SSA, which SSADH then oxidizes to succinate — the terminal, committed step (established across taxa; human SSADH, Kim et al. 2009, PMID 19300440; E. coli NAD-SSADH induced on GABA as sole N-source, PMID 7004491). KEGG maps PP_2488 to butanoate metabolism and alanine/aspartate/glutamate metabolism (GABA node).
2. Polyamine (putrescine) catabolism. Putrescine degradation converges on GABA/SSA. In P. putida the NADP-dependent SSADH is putrescine-induced (PMID 3355840); the NAD-preferring sad-I provides an alternative/parallel SSA-oxidizing activity.
3. Aromatic 4-hydroxyphenylacetate (4-HPA) / tyrosine catabolism. The 4-HPA meta-cleavage pathway yields SSA as an end product; notably, the P. putida NAD-preferring SSADH is specifically induced by growth on 4-hydroxyphenylacetate (PMID 3355840), and KEGG lists PP_2488 under tyrosine metabolism. This is the most distinctive candidate physiological role separating the sad enzymes from the GABA-operon gabD.
4. General aldehyde detoxification. Given its promiscuity and its genomic neighborhood of aldehyde/reductase genes, sad-I also acts as a housekeeping scavenger of reactive C4 (and related) semialdehydes (PMID 25888791, 40421117, 39406738).

Regulatorily, in E. coli the sad/yneI gene is controlled by the LysR-type regulator PtrR/YneJ (PMID 35508583), distinct from the GabR/σ-based control of gabTD, reinforcing that sad- and gabD-type SSADHs are separately deployed.

6. Localization

sad-I is a soluble cytoplasmic enzyme. Bioinformatic analysis found no transmembrane segment (max Kyte-Doolittle hydropathy 0.96, below the ~1.6–2.0 TM threshold; zero windows >1.6), a net-hydrophilic GRAVY of −0.071, and a polar N-terminus with no signal-peptide core; UniProt reports no signal peptide, transmembrane region or targeting sequence. Its substrate SSA is generated by soluble cytoplasmic transaminases/ring-cleavage enzymes, consistent with cytosolic action. (In eukaryotes the orthologous SSADH is mitochondrial-matrix, PMID 19300440; bacteria lack that compartment and the enzyme is cytosolic.)

7. Supported and refuted hypotheses

Supported
- H1 — sad-I is a NAD⁺-dependent SSADH catalyzing SSA→succinate. (DB annotation + conserved catalytic Cys265/Glu362 + NAD-preference Lys157 + class biochemistry.)
- H2 — sad-I belongs to the NAD-preferring sad/yneI clade, distinct from NADP-type gabD. (Sequence orthology 41.9 % to Sad vs 37.5 % to GabD; clade structure of the 4 paralogs.)
- H3 — sad-I is soluble/cytoplasmic. (No TM/signal; net-hydrophilic.)
- H4 — Broader/promiscuous aldehyde specificity + detoxification role. (n-butyraldehyde, malate semialdehyde activity of the class.)

Refuted / disfavored
- sad-I is not the dedicated GABA-nitrogen operon SSADH — that role is filled by gabD-I/PP_0213 (in operon with gabT/PP_0214). sad-I is not gene-linked to gabT.
- sad-I is not a membrane or secreted protein.

8. Limitations and future directions

• No PP_2488-specific enzymology. Km/kcat, exact cofactor ratio, oligomeric state and substrate scope of the specific protein are inferred, not measured. Recombinant expression + steady-state kinetics on SSA, glutarate-semialdehyde, malate-semialdehyde and n-butyraldehyde would define specificity directly.
• sad-I vs sad-II division of labor is unresolved; a clean knockout/complementation and growth phenotyping on GABA, putrescine and 4-HPA would assign the dominant in-vivo pathway.
• Structure. An AlphaFold model exists (AlphaFoldDB Q88K05); experimental structure with NAD⁺/SSA would confirm the modeled active site.
• KEGG additionally lists the generic K00135 ortholog under lysine degradation (glutarate-semialdehyde dehydrogenase, EC 1.2.1.20); whether sad-I contributes to glutarate metabolism in vivo (vs the dedicated CoA-independent pathway) remains to be tested.

Key references

• PMID 3355840 — Two SSADHs in P. putida (NAD-preferring vs NADP; induction by 4-HPA vs putrescine).
• PMID 7004491 — E. coli NAD- vs NADP-specific SSADH; substrate range; GABA induction.
• PMID 23229889 — Crystal structure + mutagenesis of NAD(P)⁺ SSADH YneI (catalytic Cys268, Trp136, Glu365; Lys160 NAD⁺ preference).
• PMID 25888791 — SSADH reaction and detoxification role.
• PMID 19300440 — SSADH as terminal GABA-degradation enzyme (human, mitochondrial).
• PMID 35508583 — E. coli Sad ≡ YneI; PtrR/YneJ regulation.
• PMID 40421117, 39406738 — SSADH substrate promiscuity.
• PMID 12534463 (Nelson 2002), 26913973 (Belda 2016) — KT2440 genome/annotation.

Artifacts

• OpenScientist final report
• OpenScientist final report